Novartis Investigator Site

Baltimore, Maryland 21236

0 studies enrolling now · 4 studies all time

What they study most

Asthma, Chronic Obstructive Pulmonary Disease, Diabetes Mellitus, Type 2, Systemic Sclerosis, Scleroderma

Studies at this site

• Efficacy and Tolerability of STI571 (Imatinib Mesylate) for the Treatment of Fibrosis in Participants With Systemic Sclerosis — Completed
• Assessment of the Skin-concentration of Vildagliptin 50 mg Every 12 Hours for 10 Days in Healthy Subjects and Patients With Type 2 Diabetes — Stopped early
• Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma — Completed
• Safety and Efficacy of Multiple Doses of Canakinumab (ACZ885) in Chronic Obstructive Pulmonary Disease (COPD) Patients — Completed